AKT1 and metabolic syndrome: Our data from the present study showed that Ang-(1–7) at MetS does not act through the MRGD but through the Mas, stimulating eNOS activation and probably NO production and reducing protein and lipid oxidation and increasing SOD activity dependent to AKT (Patel et al., 2016).